Kennedy Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-189,671
Closed -$5.67M 720
2019
Q1
$5.67M Sell
189,671
-8,604
-4% -$247K 0.13% 291
2018
Q4
$6.12M Sell
198,275
-7,807
-4% -$285K 0.15% 240
2018
Q3
$7.81M Sell
206,082
-24,225
-11% -$916K 0.15% 252
2018
Q2
$8.84M Sell
230,307
-139,957
-38% -$4.72M 0.16% 207
2018
Q1
$12.5M Buy
370,264
+52,396
+16% +$2.01M 0.24% 112
2017
Q4
$14.1M Buy
317,868
+177,020
+126% +$8.06M 0.25% 103
2017
Q3
$7.05M Sell
140,848
-14,226
-9% -$727K 0.13% 275
2017
Q2
$8.19M Sell
155,074
-25,861
-14% -$1.39M 0.16% 206
2017
Q1
$10.1M Buy
180,935
+147,157
+436% +$8.12M 0.18% 195
2016
Q4
$1.76M Buy
+33,778
New +$1.63M 0.03% 615

Other funds holding PBH

Kennedy Capital Management's PBH Position: Q2 2019 in Review

Kennedy Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2019, closing a stake of 189,671 shares — an estimated $5.67M sold.

Kennedy Capital Management first reported a position in PBH in Q4 2016 and held it in 10 quarters. The position peaked at $14.1M in Q4 2017. 212 funds tracked by Wall St. Rank hold PBH as of Q2 2019.

  • Kennedy Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2019 after selling out during the quarter.
  • Kennedy Capital Management sold 189,671 Prestige Consumer Healthcare shares in Q2 2019, an estimated $5.67M.
  • Kennedy Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 10 quarters.
  • Kennedy Capital Management's Prestige Consumer Healthcare position peaked at $14.1M in Q4 2017.
  • 212 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2019.

Based on Kennedy Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.